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Abstract
Background: Enterovirus 71 (EV71) has emerged as a neuroinvasive virus responsible for several large outbreaks in the Asia-
Pacific region while virulence determinant remains unexplored.
Principal Findings: In this report, we investigated increased virulence of unadapted EV71 clinical isolate 237 as compared
with isolate 4643 in mice. A fragment 12 nucleotides in length in stem loop (SL) II of 237 59-untranslated region (UTR) visibly
reduced survival time and rate in mice was identified by constructing a series of infectious clones harboring chimeric 59-
UTR. In cells transfected with bicistronic plasmids, and replicon RNAs, the 12-nt fragment of isolate 237 enhanced
translational activities and accelerated replication of subgenomic EV71. Finally, single nucleotide change from cytosine to
uridine at base 158 in this short fragment of 59-UTR was proven to reduce viral translation and EV71 virulence in mice.
Results collectively indicated a pivotal role of novel virulence determinant C158 on virus translation in vitro and EV71
virulence in vivo.
Conclusions: These results presented the first reported virulence determinant in EV71 59-UTR and first position discovered
from unadapted isolates.
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Introduction
Enterovirus 71 (EV71), a member of the genus Enterovirus of
Picornaviridae family, is a non-enveloped virus with positive, single-
stranded RNA of about 7400 nt [1]. Its viral genome encodes a
large polyprotein with a single open reading frame (ORF) flanked
by 59-untranslated region (UTR) and 39-UTR. Polyprotein divides
into three regions [2]: P1 containing capsid proteins VP1, VP2,
VP3 and VP4; P2 and P3 containing non-structural proteins (2A,
2B, 2C, 3A, 3B, 3C and 3D) crucial to virus replication. Genome
translation is initiated by a cap-independent mechanism mediated
by internal ribosome entry site (IRES) in highly structured 59-
UTR [3,4]. Six major stem loop (SL) structures essential to viral
RNA replication [5] and translation [6,7] were identified within
picornavirus 59-UTR [2,8].
Clinical EV71 manifestations include hand-foot-and-mouth
disease (HFMD), herpangina and severe neurological complica-
tions like aseptic meningitis, brainstem encephalitis, and acute
flaccid paralysis in children under five years of age [9].
Neurovirulence of EV71 first drew public concern in 1975 in
Bulgaria when 44 people died of polio-like disease [10]. EV71 was
correlated with epidemics of neuroinvasive diseases in New York,
Malaysia, Japan, Australia, Taiwan, China, Hungary and Hong
Kong [11,12,13,14,15,16,17,18]; it is thus regarded as an
emerging neurotropic enterovirus besides poliovirus.
Molecular determinant for EV71 virulence remains unexplored
[19,20]. With generation of mouse-adapted EV71, glycine (G) to
glutamic acid (E) change at amino acid 145 in VP1 was identified
as determinant for the adapted virulence [21,22]. Adaptation-
derived mutation from lysine (K) to isoleucine (I) at amino acid
149 of VP2 improves virus replication in CHO cells [21,22].
Mutations in capsid proteins as receptor binding sites determining
host range were identified in these adapted strains, most proven
responsible for adapted virulence. This raises a possibility of other
virulence determinants’ effects masked by species tropism.
Virulence determinant of other enteroviruses has been reported.
Nucleotide 480, 481 and 472 in poliovirus 59-UTR were cited as
neurovirulence determinants of poliovirus Type 1, 2 and 3,
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at nucleotide 103 in 59-UTR attenuates poliovirus neurovirulence
[26]. Also, SL II in 59-UTRs of coxsackievirus (CV) B1 and B3
determines their cardiovirulence phenotype [27,28,29]. These
studies reported contributions of 59-UTR to viral virulence, while
few reports currently indicate the importance of 59-UTR to EV71
virulence.
To determine whether the 59-UTR of naturally circulating
EV71 contributes to virulence as other enteroviruses, we
correlated 59-UTR and differential virulence of clinical isolates
in mice. We further mapped virulence determinant using
recombinant viruses generated from a series of infectious clones
harboring chimeric 59-UTRs. Effect of the identified determinant
on virus translation and replication in vitro was examined via
bicistronic plasmids and subgenomic replicons. Tissue viral load
was also examined to gauge effect of the determinant on virus
replication in vivo.
Materials and Methods
Ethics Statement
All experiments were conducted in accordance with the
guidelines of Laboratory Animal Center of National Cheng Kung
University. The Institutional Animal Care and Use Committee of
National Cheng Kung University approved all animal protocols.
(Approved protocol No. IACUC-097026).
Cells and Viruses
RD cells (ATCC CCL-136
TM) were cultured in DMEM
medium supplemented with 10% fetal bovine serum (FBS), L929
cells (ATCC CCL-1
TM) were cultured in EMEM medium with
10% FBS and 1% sodium pyruvate added. RD cells were used for
infectious RNA transfection, virus production and plaque assay.
L929 cells were used for IRES activity assay. Isolate 4643 was
isolated in 1998 in Virology Laboratory of National Cheng Kung
University Hospital, isolate 237 obtained in 1986 at Kaohsiung
Medical University Hospital. Mouse-adapted MP4 generated by
four serial passages in brains of mice was used as backbone for
gene manipulations to study EV71 virulence in mice [30].
Plasmid constructions. Standard molecular cloning
techniques were used in all constructions [31]. All primer
sequences are provided in supporting information (Table S1 for
full-length infectious clones and chimeric 59-UTRs, Table S2 for
point mutations, and TableS3for bicistronic plasmidand replicons).
Full-length EV71 infectious DNA clones. Viral genomic
RNAs of MP4, 4643 and 237 were extracted using Viral Nucleic
Acid Extraction Kit (Geneaid). RNAs were reverse-transcribed
with primer RT-50 and SuperScript II reverse transcriptase
(Invitrogen). The cDNAs were PCR-amplified with primers 4643F
and RT-50 by using KOD plus DNA polymerase (Toyobo). The
7.4-kb genome of MP4, 4643 and 237 were digested with EcoRI
and EagI (New England Biolabs) and then ligated to a pre-digested
modified pUC19.
Infectious clones harboring various 59-UTRs. The
infectious clone 4643M was constructed by replacing 59-UTR of
template MP4 with sequence of 4643. Briefly, 4643 59-UTR was
PCR-amplified from full-length 4643 infectious clone with primers
4643F and R-EV71-5UTR. Partial VP4 gene of MP4 was
amplified with primers MP4-VP4N and R-MP4-BbvCI. Two
PCR products were mixed for overlapping PCR using primers
4643F and R-MP4-BbvCI. Purified PCR products were inserted
into template MP4 between EcoRI and BbvCI sites. Infectious
237M and other infectious clones harboring chimeric or point-
mutated 59-UTRs were likewise generated.
EV71 subgenomic replicons. Subgenomic replicon of
isolate 4643 was constructed as described [32]. Chimeric or
point-mutated 59-UTRs were PCR-amplified with primers 4643F
and 5-UTR-XmaI from infectious clones described above and
inserted to 4643 replicon between EcoRI and XmaI sites.
Bicistronic plasmids. Bicistronic plasmids contain beta-
galactosidase gene followed by EV71 59-UTR and firefly
luciferase gene. DNA fragments from 59-UTR to firefly
luciferase gene were PCR-amplified with primers 4643F and R-
XhoI-FLuc from various replicons constructed as described above.
The fragment was inserted to pCMV vector (Stratagene) with
EcoRI and XhoI sites. The b-galactosidase gene was then inserted to
NotI and BamHI site.
Transcription in vitro. Replicon and infectious RNAs were
transcribed in vitro from EagI-linearized DNA pladmids using
MEGAscript Kit (Ambion). RNAs were purified with Sephadex
G-50 spin columns (GE Healthcare) and quantified with Qubit
RNA BR Assay Kit (Invitrogen). RNA integrity was tested by
standard agarose gel electrophoresis.
Virus production from infectious DNA clones. Infectious
RNAs were transfected into RD cells with TransMessenger
Transfection Reagent (Qiagen) following manufacturer’s
instruction. Transfected cells were incubated at 37uC and
harvested until 90% of cells developed cytopathic effect (CPE).
Titers of experimental recombinants were determined by plaque
assay.
Transfection and reporter activity assay. Bicistronic
DNA plasmids were transfected to L929 cells with TurboFect in
vitro Transfection Reagent (Fermentas) according to manufacturer’s
protocol. PBS washed cells were lysed in 1X Reporter Lysis Buffer
(Promega) upon harvest. Reporter activities were analyzed with
Luciferase Assay System (Promega) and b-Galactosidase Assay
System (Promega). For virus replication assay, replicon RNAs were
transfected to L929 cells with TransMessenger Transfection
Reagent (Qiagen); cell lysates were harvested at intervals with 1X
Reporter Lysis Buffer, as described earlier. All reporter activity
assays were performed in triplicate and presented as relative fold
change.
Sequences and RNA secondary structure prediction. Full-
length genomic sequences of EV71 clinical isolates 237 (FJ357380)
and 4643 (AF304458) are available on Genebank. RNA secondary
structures were predicted by mfold [33] and RNAStructure Version
5.3 [34] with pre-set parameters; drawings were produced with
RnaViz [35].
Western blot. Cell lysates were separated on 10% SDS-
polyacrylamide gels and transferred to polyvinylidene difluoride
membranes. EV71 proteins were probed with MAb979 (Millipore)
in 1% BSA at 1:2000 dilution. HRP-conjugated anti-mouse IgG
(Abcam) diluted in 1% BSA at 1:5000 dilutions was used to probe
MAb979. Protein signals were developed in ECL reagents (Perkin
Elmer) and exposed to X-ray films (Kodak). Antibody against b-
actin (Sigma) was included as control, band density rated with
ImageJ.
Animal experiments. Specific-pathogen-free, three-day-old
Institute of Cancer Research (ICR) mice (from Laboratory Animal
Center of National Cheng Kung University) were intraperitoneally
(i.p.) or intracranially (i.c.) inoculated with pre-determined dose of
various viruses. Control mice were given control viral medium
instead of virus suspension. Mice were observed twice daily for
clinical signs, body weight and survival for 14 days. Clinical signs
were scored: 0, healthy; 1, ruffled fur and hunchbacked
appearance; 2, wasting; 3, limb weakness; 4, limb paralysis; 5,
moribund or dead [36]. To determine tissue viral load, mice were
perfused with saline after euthanasia. Selected tissues were
Determinant of EV71 Virulence in Mice
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homogenized in viral medium, disrupted by three freeze-thaw
cycles, then centrifuged. Virus titers in clarified supernatants were
determined by plaque assay and expressed as log pfu per mg of
tissue.
Statistics. Statistical analyses were performed using
GraphPad Prism 5 (GraphPad). Relative translational activity
was analyzed by t-test with results plotted as mean 6 standard
error of the mean (SEM), survival rates by log-rank analysis and P
value of ,0.05 significant.
Results
59-UTR correlates with distinct virulence of two
unadapted EV71 isolates
Virulence of two EV71 clinical isolates 4643 and 237, without
further adaptation in cell culture or animals, were compared using
a mouse infection model. Isolate 237 reduced survival time and
rate of infected mice as compared with isolate 4643 (16.7% vs.
100%, P,0.005) (Fig. 1A). Severe clinical signs appeared in 237
infected mice while 4643 caused no clinical diseases (Fig. 1B).
Results indicated EV71 clinical isolate 237 as more virulent than
isolate 4643 in mice.
To identify genetic determinant for the differential virulence of
EV71 clinical isolates 4643 and 237, full-length viral genomes of
the two isolates were cloned and sequenced. Nucleotide sequence
of 59-UTRs and 39-UTRs, and amino acid sequence of coding
regions of the two isolates were analyzed. Phylogenetic analysis of
VP1 region classified isolate 4643 as C2 genotype, and 237 as B1
(data not shown). The two isolates shared 85.1 % identity for 59-
UTR, and 88.8 % for 39-UTR. Amino acid identity for coding
regions of the two isolates was 89.9 %. These analyses revealed
numerous genetic variations, located throughout the entire viral
genome, that were potential molecular determinant for the
differential virulence of EV71 in mice.
The contribution of 59-UTR to enterovirus virulence has been
extensively reported as mentioned earlier, contribution of 59-UTR
to EV71 virulence was thus first examined. To study EV71
virulence in a mouse infection model, a mouse-adapted MP4,
recovered by four serial passages of isolate 4643 in brains of mice,
was used as backbone for gene manipulations [30]. To determine
correlation between EV71 59-UTR and differential virulence in
mice, 59-UTR of the backbone MP4 was replaced by sequences of
isolates 4643 and 237 (Fig. 2). Virulence of resulted recombinant
viruses 4643 M, 237 M, and backbone MP4 were tested in mice.
No 237 M infected mice survived at Day 8 post-inoculation, while
over 50% of 4643 M inoculated mice survived 14 days after
inoculation (0% vs. 57%, P,0.01) (Fig. 1C). Virus 237M caused
paralysis and mortality in all cases; four of seven infected by
4643M were paralyzed, three dead (Fig. 1D). Survival rate and
clinical scores of MP4-infected mice were both comparable to
4643M infection (50% vs. 57%, P.0.05) (Fig. 1C and 1D).
Average survival time (AST) for MP4, 4643M and 237M
inoculated mice were .11, .11.4, and 6.9 days (Fig. 2),
respectively, evidently correlation of 59-UTR with differential
virulence of the two unadapted EV71 clinical isolates in mice.
Figure 1. The 59-UTR correlates with the distinct virulence of EV71 in mice. Three-day-old ICR mice were i.p. inoculated with unadapted
EV71 clinical isolate 4643 or 237 at 5610
4 pfu/mouse (A, B), and 59-UTR-replaced recombinant virus 4643 M or 237 M and backbone MP4 at
5610
4 pfu/mouse (C, D). The survivals (A, C) and clinical scores (B, D) of mice were monitored for two weeks. Mock control mice were given viral
medium.
doi:10.1371/journal.pone.0027082.g001
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genotype-specific phenotype, we tested the effect of 59-UTR from
another B genotypic EV71 clinical isolate, N7008, which showed
comparable virulence with isolate 4643 in mice. Mice infected
with virus N7008M (MP4 backbone with N7008 59-UTR) also
showed increased survival rate as compared with 237M (60% vs.
0%, P,0.05) (Fig. S1). This confirmed that the increased virulence
of isolate 237 in mice is specific to 59-UTR, but not a general
genotypic phenotype.
Mapping of virulence determinant in EV71 59-UTR
To locate virulence determinant in 59-UTR, infectious clones
harboring chimeric 59-UTR were constructed and recombinant
viruses generated were inoculated into mice (Fig. 2). AST of mice
infected with 237/4643M, 4643CL-237M were 5.9 and 5.3 days,
respectively, while 4643/237M and 4643SLII-237M infected mice
survived more than 11.5 days (Fig. 2). Presence of 4643 SL II
prolonged AST of mice, suggesting a dominant role of SL II on
EV71 virulence.
SL II in EV71 59-UTR is secondary structure made of about 75
nucleotides in length (Fig. 3). EV71 isolates 4643 and 237 share
74% sequence identity in SL II. Among the 20 varied nucleotides,
10 located in a short region of nt. 142–162 which formed the
upper domain of 4643 SL II (Fig. 3). To ferret out virulence
determinant in SL II, we introduced chimeric SL II derived from
isolates 4643 and 237, based on these sequence alignment and
predicted secondary structure, to backbone 4643SLII-237M.
Clone USLIIM contains upper SL II of 237 and lower half from
4643; LSLIIM contains upper SL II of 4643 and lower domain
from 237. Top loop of USLIIM SL II was restored to sequence of
4643 to generate USLIIM-LOOP (Fig. 4). Mice infected with
USLIIM and USLIIM-LOOP showed AST of 4.7 and 4 days,
respectively. Upper stem of 4643 SL II prolonged AST of infected
mice to .11.7 days, indicating the short fragment as attenuating
virulence of USLIIM in mice (LSLIIM, Fig. 4). Collectively, results
suggested a molecular determinant of EV71 virulence in mice
located in the SL II upper stem, which is made of nt. 141–146 and
nt. 155–160 of 59-UTR.
Figure 2. Molecular determinant of EV71 virulence in mice was mapped to SL II. Genomic structure of EV71 shown in the upper part and
schematic presentation of the compositions of 59-UTRs of infectious clones are shown in the lower panel. Open, closed, and slash box represent
sequence of isolates 4643, 237, and MP4 respectively. Number and average survival time of mice infected with these clone-derived viruses were also
indicated. { Survival time of mice alive on Day 14 post-inoculation was calculated as 14.
doi:10.1371/journal.pone.0027082.g002
Figure 3. Multiple genetic variations concentrate in the SL II upper domain. Secondary structures of SL II of isolate 237 and 4643 predicted
using RNA Dyalign of RNAstructure Version 5.3 are shown in the upper part. Sequence alignment of the two SL IIs revealed 20 nucleotide variations,
indicated as bold in predicted secondary structure of 237 SL II, 10 concentrated from nucleotide 142 to 162 which form the SL II upper domain as
boxed.
doi:10.1371/journal.pone.0027082.g003
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and replication
To study effect of the SL II upper stem on viral translation,
bicistronic plasmids (Fig. 5A) harboring chimeric 59-UTRs were
constructed and transfected into L929 cells; reporter activities were
determined. Presence of 4643 SL II upper stem correlated with
reduced translational activity as compared with 237 in L929 cells
(4643, 237CL-4643, 4643/237, 4643SLII-237 and LSLII in
Fig. 5B) (all P,0.005) while SL II upper stem of 237 enhanced
translational activity (237, 237/4643, 4643CL-237, USLII and
USLII-LOOP) (all P,0.005), indicating SL II upper stem as
regulating translational activity of EV71.
Effect on viral translation was further confirmed by monitoring
viral translated products in full-length viral RNA transfected cells.
Western blot analysis showed that at four hours post transfection,
translated viral proteins could be detected in USLIIM transfected
cells while only trace protein expression was observed in cell lysate
of 4643SLII-237M transfection. Higher protein levels were probed
in cells transfected with USLIIM than with 4643SLII-237M at
various time points (Fig. 5C). This confirmed that the upper
domain of SL II affects viral translation in cells.
Although all recombinant viruses generated in this study
replicated efficiently in RD cells (human rhabdomyosarcoma),
the fact that NIH3T3 (mouse fibroblast), N18 (mouse neuroblas-
toma) and L929 cells do not efficiently support EV71 infection led
to difficulties to determine effect of SL II upper domain on growth
phenotype in mouse cell lines (data not shown and [37]).
Alternatively, L929 cells were transfected with replicon RNAs of
USLII and 4643SLII-237, and firefly luciferase activities at 4, 6
and 12 hours post-transfection were evaluated to determine
regulation of SL II upper domain on virus replication. Relative
luciferase activity of USLII was significantly higher than
4643SLII-237 at 6 and 12 hours post-transfection (Fig. 5D),
indicating that the SL II upper domain of EV71 59-UTR regulates
both viral translation and replication.
Upper domain of SL II affects EV71 replication
Effect of SL II upper domain on virus replication in mice was
examined. Virus titers (log pfu/mg of tissue) in brain, spinal cord
and posterior limb muscle of USLIIM infected mice were 0.9–1.6,
2.1–2.9 and 2.8–3.4, respectively. No virus was recovered from
brain of mice inoculated with 4643SLII-237M, while virus titer in
spinal cord was 20.92 log pfu per mg of tissue. Muscle of
4643SLII-237M infected mice was detected a reduced virus titers
of 0.4–1.8 log per mg of tissue as compared with USLIIM
infection (P,0.05) (Fig. 6A). Reduced replication of 4643SLII-
237M in brain was confirmed by direct i.c. inoculation. Virus titers
in USLIIM injected brains were about 2 logs higher than in
4643SLII-237M infected brains (P,0.05) (Fig. 6B), confirming
that the SL II upper domain of isolate 4643 reduces virus
replication in mice.
Some mice infected with 4643SLII-237M showed paralysis as
with USLIIM. To determine correlation between paralysis and
tissue viral load, selected tissues of 4643SLII-237M infected mice
were taken for plaque assay after paralysis onset. Among 10
paralyzed mice, virus titers (log pfu/mg of tissue) of 0–1.78 were
detected in muscles. Only one brain of ten was detected a low virus
titer of 21.39 log pfu per mg of tissue while two spinal cord
samples showed virus titers of 20.92 (Fig. 6C). This result
suggested that upper SL II may also regulate neurovirulence of
EV71.
Single nucleotide substitution attenuates EV71 virulence
Nucleotide substitutions were introduced into SL II upper stem
of virulent USLIIM to define minimum genetic element of EV71
virulence (Fig. 7A). RNA secondary structure prediction showed
that only nucleotide change of C158U caused alteration in SL II
structure (Fig. S2). Viruses USLIIM, USLIIM-C142U, USLIIM-
A146G and USLIIM-142/159 showed similar virulence while
USLIIM-C158U prolonged AST and survival rate of infected
mice as compared with USLIIM infection (40% vs. 0%, P,0.005)
Figure 4. Short stem in the upper domain of SL II determines EV71 virulence in mice. The RNA secondary structure of 4643 SL II predicted,
as described in Materials and Methods, is shown in the left panel. Composition of chimeric SL IIs of infectious clones is shown in the middle panel.
Open and closed boxes represent sequence of isolates 4643 and 237, respectively. USLII and LSLII were generated by replacing nucleotides in the
upper or lower half of 4643 SL II with corresponding sequences of isolate 237. Top loop of USLII was further replaced with corresponding sequence of
isolate 4643 to generate USLII-LOOP. The average survival time of mice infected with recombinant viruses generated from these clones is shown in
the right panel. Base numbers are from EV71 isolate 4643. { Survival time of mice alive on Day 14 post- inoculation was calculated as 14.
doi:10.1371/journal.pone.0027082.g004
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showed paralysis during post-inoculation Days 6–9, with only
three paralyzed mice dying at Days 8–10 (Fig. 7C). Nucleotide
substitution of C158U also reduced translational activity mediated
by USLII 59-UTR (P,0.005), while introduction of U158C
reversion to 4643 59-UTR led to increased translational activity
(P,0.05) (Fig. 7D). Results indicated that position C158 in SLII is
a major determinant for viral translation and EV71 virulence.
Discussion
EV71 Isolates 237 and 4643 were isolated in Taiwan as of
1986 and 1998, respectively. Isolate 4643 was isolated from a
fatal case of encephalitis during the 1998 outbreak afflicting
thousands of children, with 405 severe cases and 78 deaths.
Isolate 237 was obtained from one patient during HFMD
epidemic in 1986. Viral genomes of low-passage viruses were
cloned as infectious types to prevent further genetic change
during replication cycles, as well as for full-length genomic
sequencing. No further cell culture adaptation was performed,
meaning the obtained sequences were regarded as representative
of original viruses. To study pathogenicity, we tested virulence of
both isolates in a mouse infection model. It was interesting that,
for unknown reasons, unadapted Isolate 4643 caused severe
disease in humans but was avirulent to newborn mice; Isolate 237
caused only mild human infection but proved highly lethal to
mice. To learn more about EV71 virulence and pinpoint the
mechanism for the differential virulence, we performed this study
in mice. Accumulated reports have stressed contributions of 59-
UTR in viral replication and virulence of enteroviruses
[25,26,27,29,38,39,40,41,42,43] whereas evidence on the impor-
tance of 59-UTR to EV71 virulence is limited. Our chief
objective of this study is to identify potential virulence
determinant in the 59-UTR of unadapted EV71 in mice. With
generation of a series of infectious clones harboring various 59-
UTR, we mapped a genetic determinant of EV71 virulence to SL
II upper stem. Further characterization of this fragment proved a
single nucleotide change of C158U as sufficient to attenuate
EV71 virulence. The identified determinant was proven to
regulate virus translation in L929 cells and replication in mice.
The importance of SL II to viral life cycle and virulence is
supported by other studies. Point mutations in SL II of Mahoney
Figure 5. Short fragment of SL II regulated viral translation and replication in vitro. (A) Construction of dual reporter plasmid to determine
translational activity mediated by EV71 59-UTR. (B) Relative translational activities mediated by various 59-UTRs. Dual reporter plasmids with various
59-UTR were transfected into L929 cells, firefly luciferase activity determined 24 hours post-transfection and normalized with b-galactosidase activity.
Relative translational activity to isolate 237 is shown as fold increase. (C) Effect of SL II on virus translational activity. Infectious RNAs USLIIM and
4643SLII-237M were transfected into L929 cells, lysates harvested at 2, 4, 6 and 8 hours post-transfection. Western blot was performed by MAb979 to
detect viral translated products. Collective band density of each time-point was rated with ImageJ and expressed as fold increase relative to band
density of USLIIM at four hours post-transfection. Western blot analysis of actin was included as control for normalization. (D) Effect of SL II on viral
replication. Replicon RNAs of USLII and 4643SLII-237 were transfected into L929 cells and the cell lysates were harvested at 4, 6 and 12 hours post-
transfection; luciferase activities at 4 hours reflect transfection efficiency. Their replication rates were expressed as fold increase of firefly luciferase
activity at 6 or 12 hours versus 4 hours post-transfection.
doi:10.1371/journal.pone.0027082.g005
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translation and RNA replication in mouse cells, while SL II
deletion mutants with 6–10 bases deleted cause non-viable
phenotype [39,44]. Nucleotide substitution at base 133 of A by
G in SL II of Mahoney virus enhances efficiency of viral plus-
strand RNA synthesis in Poliovirus receptor (PVR) expressing
mouse cells [45]. SL II also determines cardiovirulence of CVB3
clinical isolates in a murine model [27,46,47]. These studies
Figure 6. Short stem of SL II affected virus replication in mice. (A) Effect of 237 SL II upper domain on virus replication in vivo. Three-day-old
ICR mice were i.p. inoculated with USLIIM or 4643SLII-237M at 5610
4 pfu/mouse. Brain, spinal cord and posterior limb muscle were recovered at Day
3 post-inoculation and virus titer determined with plaque assay.
a: no virus detected in brain of mice infected with 4643SLII-237M.
b: virus detected in
only one spinal cord sample from 4643SLII-237M infected mice. (B) Effect of 237 SL II upper domain on viral replication in brain. Three-day-old ICR
mice were given 2,500 pfu/dose of USLIIM or 4643SLII-237M recombinant viruses via i.c. route. Brains of infected mice were recovered post-
inoculation.
a: virus was detected only in one brain of 4643SLII-237M infected mice. (C) Correlation between tissue viral load and paralysis in 4643SLII-
237M-infected mice. Mice were i.p. inoculated with 4643SLII-237M at 5610
4 pfu/mouse. Brain, spinal cord and muscle were recovered after posterior
limb paralysis was observed.
a: virus was detected in one brain of 10 paralyzed mice.
b: virus was detected in two spinal cord samples from 10
paralyzed mice. Results represent virus titer (log10 pfu) per milligram of tissue.
doi:10.1371/journal.pone.0027082.g006
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viral virulence is located in the SL II of EV71 59-UTR.
Virus replication is a key factor determining virulence [48,49].
Interactions between a cloverleaf directing viral RNA replication
and the IRES domain mediating viral translation greatly affect
virus replication. Given the nature of positive sense of enterovirus
RNA, viral genome serves as mRNA for viral protein synthesis
once released into infected cells. Binding of host translational
factors to the IRES domain initiates viral RNA translation.
Amongst those host proteins involved, poly(rC) binding protein
(PCBP) binds to the cloverleaf, and to the SL IV in IRES domain
with higher affinity in the absence of viral proteins. When enough
viral proteins accumulate, viral 3CD binds to the cloverleaf,
yielding a 2-log increased binding affinity of PCBP to this
structure, and ultimately switch from viral translation to RNA
synthesis [50,51]. Increased translational activity mediated by viral
59-UTR hence implies faster virus replication and illustrates viral
translation as an important early event regulating virus replication
and virulence. Correlation between translational activity mediated
by viral 59-UTR and virulence is widely reported. Nucleotide 480,
481 and 472 which attenuates neurovirulence of poliovirus Type
1, 2 and 3, reduces viral translation in neuronal cells [23,24,38]. A
single nucleotide mutation at position 103 attenuates neuroviru-
lence and reduces in vitro translation in human neuronal cell lysate
[26]. Mechanism for the regulation generally accepted: these
single nucleotide changes alter RNA secondary structure and
binding affinity to host factors, thereby reducing viral translation
and virulence [52,53]. Correlation between viral translation and
EV71 virulence was also established in this study. The nucleotide
158 we identified as genetic determinant for EV71 virulence also
regulates viral translation in L929 cells. Combined with software
prediction that C158U caused alteration in RNA secondary
structure of SL II, we therefore propose that nucleotide change of
C158U may apply the same mechanism to determine viral
translation and virulence.
Another line of evidence portends existence of tissue-specific
proteins and their differential binding affinities to 59-UTR of
virulent and attenuated strains. It was reported that tissue-specific
expression and differential RNA-binding abilities of polypyrimi-
dine-tract-binding protein (PTB) and its neural-specific homologue
nPTB determine cell-specific translation and neurovirulence of
poliovirus [54]. In this study, differential replication abilities of
virulent USLIIM and attenuated 4643SLII-237M in CNS and
muscle are noticed; replication of attenuated virus in brain is not
improved by direct i.c. inoculation. Since USLIIM and 4643SLII-
237M share exactly the same coding region from template MP4;
possibilities of differential distribution of cellular receptor that
mediates viral entry or differential binding abilities to cellular
receptor are excluded. The fact that viral genomes of USLIIM and
4643SLII-237M differ only in the upper SL II, part of IRES that
mediates virus translation, supports a hypothesis that neural-
specific protein(s) binds to SL II of USLIIM with higher affinity
than 4643SLII-237M.
Besides differential virus replication in brain, recombinant virus
USLIIM and 4643SLII-237M showed distinct neurovirulence in
mice. Some but not all inoculated with attenuated virus 4643M,
4643SLII-237M or USLIIM-C158U displayed posterior limb
paralysis at about Day 6 post-infection and gradually recovered
asymptomatic status. Possible causes of paralysis are brain
invasion, spinal cord injury and muscle cell destruction. Our
tissue viral load analysis on paralyzed mice caused by 4643SLII-
237M revealed quite a low virus titer in only one brain (21.39 log
pfu/mg), slightly higher titers in two spinal cord samples
(20.92 log pfu/mg), and a higher amount of virus in muscle (0–
1.78 log pfu/mg) which we believe to cause the observed temporal
paralysis. Difference of virus titer in brain and spinal cord is
consistent with previous reported observation that EV71 spreads
from the lower to upper segment of spinal cord, then ascends to
the brain in mice [36], but it is highly unlikely that the extremely
low amount of virus in brain and spinal cord causes paralysis, not
to mention that only in one brain and two spinal cord samples
from ten paralyzed mice were detected virus. In addition, reduced
EV71 replication in mice caused by 4643 SL II, especially in
muscle (,2 Dlogs), may also limit the spread of virus to central
nervous system (CNS) via retrograde axonal transport [36]. Based
on the temporal paralysis phenotype and differential virus titers
between CNS and muscle, we conclude that the upper SL II also
contributes to neurovirulence.
Interaction between host factors and viral 59-UTR is critical to
enterovirus life cycle. Importance of host factors like IGF-II
mRNA binding protein 1 (IMP-1), lupus autoantigen (La), PTB,
PCBP-1, PCBP-2, heterogeneous nuclear ribonucleoprotein A1
(hnRNP A1) and hnRNP K to RNA virus replication has been
extensively discussed [2,4]. Among them, hnRNP A1 reportedly
binds to SL II and SL V of EV71 59-UTR and contributes to
IRES-mediated viral translation and replication [55]. We have
excluded the direct contribution of hnRNP A1 to differential
virulence of EV71 according to similar response of translation
activity mediated by USLII and 4643SLII-237 to manipulated
hnRNP A1 level (our unpublished data). Yet hnRNP A1 belongs
to a large protein family with conserved functional and structural
domains; its function in EV71 replication is replaceable by hnRNP
A2 [55]. Further probe of interplay between hnRNP A1 and other
hnRNPs or host proteins is needed to disclose a regulatory
mechanism. Differential replication ability of USLIIM and
4643SLII-237M in brain of mice also supports the hypothesis
that neural-specific proteins may contribute to viral translation
and virulence mentioned above. Existence of tissue-specific protein
or differential binding affinities of cellular proteins to SL IIs
remains uncertain.
The mouse model has been extensively used to study
pathogenesis of various viruses owing to its short breeding time,
low cost and easy handling. Here the mouse model recapitulated
major EV71 diseases including paralysis, and led to our ferreting
out Nucleotide 158 as a major determinant for virus translation
and virulence in mice. We do not ambitiously imply equal
contributions of the position to EV71 virulence in human infection
before further testing in other animal models or human cell lines,
but Nucleotide 158 may still play a key role in human EV71
circulation. Our sequence analysis revealed that all seven EV71
Figure 7. Single nucleotide substitution attenuated EV71 virulence. (A) Diagram of nucleotide substitution in SL II. Dashed rectangle
represents the identified domain determining EV71 virulence. Substituted nucleotides appear in bold type; C142, A146 and C158 of USLIIM 59-UTR
were substituted with corresponding U, G and U of isolate 4643 to generate USLIIM-C142U, USLIIM-A146G and USLIIM-C158U, respectively. Clone
USLIIM-142/159 contains two nucleotide substitutions of C142U and G159A. Average survival time is shown in the right panel. Recombinant viruses
USLIIM, USLIIM-C142U, USLIIM-A146G, USLIIM-C158U and USLIIM-142/159 were i.p. inoculated to three-day-old ICR mice at 5610
4 pfu/mouse.
Survival (B) and disease severity (C) were monitored for two weeks. (D) Effect of nucleotide substitution on translational activity mediated by EV71 59-
UTR. Point mutated bicistronic plasmids were transfected into L929 cells as described above, reporter activity determined 24 hours post-transfection.
Relative translational activity is shown as fold increase of normalized luciferase activity to USLII.
doi:10.1371/journal.pone.0027082.g007
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randomly selected isolates obtained in our laboratory since 1998
have U. We also analyzed 184 EV71 sequences retrieved from
Genebank to discover about 77% of these sequences possessing U
(23% for C) at the same position. Given a high mutation rate of
RNA virus, estimated at 1610
23 to 1610
25 errors per nucleotide
per replication cycle [56], apparent fixation in wild virus might
imply Nucleotide 158 maintaining in vivo fitness only in a context
of other changes in virus genome. Recent study on HCV cited
covariance between Nucleotide 243 in HCV 59-UTR and amino
acids in NS2/NS3 proteins. It showed HCV replication declining
in response to mutation either in 59-UTR or NS2/NS3 proteins
alone, but restored in the presence of mutation in both regions
[57]. Bioinformatic and functional analysis of interaction between
EV71 Nucleotide 158 and other genome components may explain
its significance.
Causes for contrary virulence of Isolates 237 and 4643 between
humans and mice remain unclear. One direct speculation is
existence of species-specific proteins in human and mice that
interact differentially with viral 59-UTR, and therefore affect viral
translation, replication and virulence. Recently, scanvenger
receptor B2 (SCARB2) and P-selectin glycoprotein ligand-1
(PSGL-1) were identified as cellular receptor for EV71 [37,58].
Virulence of EV71 isolates and recombinant viruses are being
tested in these receptor-transgenic mice to determine whether
expression or distribution of receptor from human affect viral
virulence in mice. In addition, humanized mouse model was
demonstrated to recapitulate human diseases of HIV-1 and
Dengue virus infection. Testing virulence in humanized mice
may resolve this contradiction [59,60,61].
This study correlates virulence of two EV71 clinical isolates with
viral 59-UTR in a mouse infection model. Molecular determinant
for this differential virulence is located in the upper SL II of EV71,
12 nucleotides in length. Point substitutions in upper SL II reveal a
pivotal role of nucleotide change of C158U on EV71 virulence.
Mechanism for regulation by the determinant involves altered
viral translation and replication ability. Our literature search
shows nucleotide 158 as both the first reported virulence
determinant in EV71 59-UTR and first position discovered from
unadapted isolates, while other studies focus on adapted
phenotype determinants.
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